|
| 33913077 | Editorial Expression of Concern: Water and sodium in heart failure: a spotlight on congestion. | Heart Fail Rev | 2021 |
| 32171760 | Natriuretic Peptide-Based Inclusion Criteria in a Heart Failure Clinical Trial: Insights From COMMANDER HF. | JACC Heart Fail | 2020 |
| 32068002 | Effects of Elamipretide on Left Ventricular Function in Patients With Heart Failure With Reduced Ejection Fraction: The PROGRESS-HF Phase 2 Trial. | J Card Fail | 2020 |
| 30537163 | Medication dosing for heart failure with reduced ejection fraction - opportunities and challenges. | Eur J Heart Fail | 2019 |
| 31554619 | Preoperative Noncoronary Cardiovascular Assessment and Management of Kidney Transplant Candidates. | Clin J Am Soc Nephrol | 2019 |
| 30452784 | Safety and Tolerability of the Chymase Inhibitor Fulacimstat in Patients With Left Ventricular Dysfunction After Myocardial Infarction-Results of the CHIARA MIA 1 Trial. | Clin Pharmacol Drug Dev | 2019 |
| 30540647 | Assessment and management of coronary artery disease in kidney and pancreas transplant candidates. | J Cardiovasc Med (Hagerstown) | 2019 |
| 28925031 | Past, present, and future of acute heart failure clinical trials-a high-risk population in search of a strategy. | Eur J Heart Fail | 2018 |
| 30217774 | A Critical Appraisal of Short-Term End Points in Acute Heart Failure Clinical Trials. | J Card Fail | 2018 |
| 30146935 | Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease. | N Engl J Med | 2018 |
| 30225882 | Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction. | Eur J Heart Fail | 2018 |
| 29952846 | A new educational program in heart failure drug development: the Brescia international master program. | J Cardiovasc Med (Hagerstown) | 2018 |
| 29921516 | Mobile health applications in cardiovascular research. | Int J Cardiol | 2018 |
| 29731121 | Sudden Death After Hospitalization for Heart Failure With Reduced Ejection Fraction (from the EVEREST Trial). | Am J Cardiol | 2018 |
| 29611010 | Expanded algorithm for managing patients with acute decompensated heart failure. | Heart Fail Rev | 2018 |
| 29511896 | Redefining biomarkers in heart failure. | Heart Fail Rev | 2018 |
| 29082676 | Lessons learned in acute heart failure. | Eur J Heart Fail | 2018 |
| 29329950 | Dual Vasopressin V1a/V2 Antagonism: The Next Step in Neurohormonal Modulation in Patients With Heart Failure? | J Card Fail | 2018 |
| 29173682 | Acute Dyspnea and Decompensated Heart Failure. | Cardiol Clin | 2018 |
| 29143416 | Plasma renin activity, response to aliskiren, and clinical outcomes in patients hospitalized for heart failure: the ASTRONAUT trial. | Eur J Heart Fail | 2018 |
| 29044915 | Pre-discharge and early post-discharge troponin elevation among patients hospitalized for heart failure with reduced ejection fraction: findings from the ASTRONAUT trial. | Eur J Heart Fail | 2018 |
| 27856497 | Intravenous Allogeneic Mesenchymal Stem Cells for Nonischemic Cardiomyopathy: Safety and Efficacy Results of a Phase II-A Randomized Trial. | Circ Res | 2017 |
| 28464398 | Finding the road to recovery: therapeutic and clinical trial implications of dysfunctional viable myocardium in heart failure with reduced ejection fraction. | Eur J Heart Fail | 2017 |
| 28433323 | Is there a clinically meaningful difference in patient reported dyspnea in acute heart failure? An analysis from URGENT Dyspnea. | Heart Lung | 2017 |
| 28356300 | Reassessing Phase II Heart Failure Clinical Trials: Consensus Recommendations. | Circ Heart Fail | 2017 |
| 28332132 | Redefining the role of biomarkers in heart failure trials: expert consensus document. | Heart Fail Rev | 2017 |
| 28153111 | Mode of Death in Heart Failure With Preserved Ejection Fraction. | J Am Coll Cardiol | 2017 |
| 28369340 | Vericiguat in patients with worsening chronic heart failure and preserved ejection fraction: results of the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED EF (SOCRATES-PRESERVED) study. | Eur Heart J | 2017 |
| 29387465 | Predictors of Post-discharge Mortality Among Patients Hospitalized for Acute Heart Failure. | Card Fail Rev | 2017 |
| 29151026 | Regional Validation and Recalibration of Clinical Predictive Models for Patients With Acute Heart Failure. | J Am Heart Assoc | 2017 |
| 28786165 | Clinical profiles in acute heart failure: one size fits all or not at all? | Eur J Heart Fail | 2017 |
| 28786154 | Real-world dosing of evidence-based medications for heart failure: embracing guideline recommendations and clinical judgement. | Eur J Heart Fail | 2017 |
| 28512159 | Employing Extracellular Volume Cardiovascular Magnetic Resonance Measures of Myocardial Fibrosis to Foster Novel Therapeutics. | Circ Cardiovasc Imaging | 2017 |
| 28647917 | Novel Endpoints for Heart Failure Clinical Trials. | Curr Heart Fail Rep | 2017 |
| 28805968 | Protein turnover in the failing heart: an ever-changing landscape. | Eur J Heart Fail | 2017 |
| 28586537 | Patient-reported outcomes in the SOluble guanylate Cyclase stimulatoR in heArT failurE patientS with PRESERVED ejection fraction (SOCRATES-PRESERVED) study. | Eur J Heart Fail | 2017 |
| 28768311 | Temporal Relation Between Myocardial Fibrosis and Heart Failure With Preserved Ejection Fraction: Association With Baseline Disease Severity and Subsequent Outcome. | JAMA Cardiol | 2017 |
| 28869332 | Renin-angiotensin blockade in heart failure with preserved ejection fraction: a systematic review and meta-analysis. | ESC Heart Fail | 2017 |
| 28656635 | Clinical trials in acute heart failure: beginning of the end or end of the beginning? | Eur J Heart Fail | 2017 |
| 28790052 | Dose of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers and Outcomes in Heart Failure: A Meta-Analysis. | Circ Heart Fail | 2017 |
| 28545624 | Drug Development for Heart Failure With Preserved Ejection Fraction: What Pieces Are Missing From the Puzzle? | Can J Cardiol | 2017 |
| 28709699 | Strategy to identify subjects with diabetes mellitus more suitable for selective echocardiographic screening: The DAVID-Berg study. | Int J Cardiol | 2017 |
| 26479144 | Rationale and design of a randomized controlled trial of allogeneic mesenchymal stem cells in patients with nonischemic cardiomyopathy. | J Cardiovasc Med (Hagerstown) | 2017 |
| 27770217 | Partial Adenosine A1 Agonist in Heart Failure. | Handb Exp Pharmacol | 2017 |
| 28004807 | Expert consensus document: Mitochondrial function as a therapeutic target in heart failure. | Nat Rev Cardiol | 2017 |
| 28041703 | Association between funding sources and the scope and outcomes of cardiovascular clinical trials: A systematic review. | Int J Cardiol | 2017 |
| 27748006 | Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial. | Eur J Heart Fail | 2017 |
| 27624622 | Safety and Tolerability of Neladenoson Bialanate, a Novel Oral Partial Adenosine A1 Receptor Agonist, in Patients With Chronic Heart Failure. | J Clin Pharmacol | 2017 |
| 25252041 | Epidemiology, pathophysiology, and in-hospital management of pulmonary edema: data from the Romanian Acute Heart Failure Syndromes registry. | J Cardiovasc Med (Hagerstown) | 2016 |
| 26634799 | Spectrum of epidemiological and clinical findings in patients with heart failure with preserved ejection fraction stratified by study design: a systematic review. | Eur J Heart Fail | 2016 |